Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT06427369
What this trial is testing

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerLung Non-Small Cell Carcinoma+2 more
Roswell Park Cancer Institute
Post-approval studies (Phase 4)Study completedNCT03853551
What this trial is testing

Osimertinib Study in Indian Patients

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
AstraZeneca 60
Large-scale testing (Phase 3)Study completedNCT00300586
What this trial is testing

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Hospices Civils de Lyon 842
Not applicableUnknownNCT05497973
What this trial is testing

Psychosocial eHealth in Advanced Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall Cell, Stage IIIALung Cancer Non-Small Cell Stage IIIBLung Cancer Non-Small Cell Stage III+2 more
Institut Català d'Oncologia 152
Early research (Phase 1)Study completedNCT00059605
What this trial is testing

Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 32
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT05144529
What this trial is testing

Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC

Who this might be right for
Lung Cancer Metastatic
Eziafa Oduah, MD, PhD, MPH 19
Large-scale testing (Phase 3)Study completedNCT00415818
What this trial is testing

Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Transgene 148
Testing effectiveness (Phase 2)Study completedNCT00363766
What this trial is testing

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)Ended earlyNCT00117351
What this trial is testing

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma, Bronchiolo-Alveolar
Millennium Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT02693080
What this trial is testing

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

Who this might be right for
Malignant Lung NeoplasmMetastatic Malignant Neoplasm in the LungNon-Small Cell Lung Carcinoma+1 more
Stanford University 19
Testing effectiveness (Phase 2)Study completedNCT00030407
What this trial is testing

Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 34
Not applicableStudy completedNCT00897234
What this trial is testing

Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers

Who this might be right for
Lung Cancer
University of Minnesota 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT03831932
What this trial is testing

Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Large-scale testing (Phase 3)Study completedNCT01774721
What this trial is testing

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Who this might be right for
Non-small Cell Lung Cancer With EGFR-Activating Mutations
Pfizer 452
Testing effectiveness (Phase 2)Study completedNCT00097214
What this trial is testing

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 57
Post-approval studies (Phase 4)UnknownNCT02103257
What this trial is testing

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Who this might be right for
EGFR Positive Non-small Cell Lung CancerAdenocarcinoma
Betta Pharmaceuticals Co., Ltd. 192
Testing effectiveness (Phase 2)Study completedNCT01864681
What this trial is testing

Combination of Metformin With Gefitinib to Treat NSCLC

Who this might be right for
NSCLCEGFR Gene AmplificationAdvanced Cancer+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 224
Not applicableStudy completedNCT04909034
What this trial is testing

A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer

Who this might be right for
NSCLC Stage IIIB~IV
Microbio Co Ltd 15
Next Page